Suresh Vedantham
Suresh Vedantham publishes mostly in Surgery, Internal Medicine and Emergency Medical Services, on topics such as Venous Thromboembolism Diagnosis and Management, Diagnosis and Treatment of Venous Diseases and Central Venous Catheters and Hemodialysis.
- World rank
- #156,923 of 7,710,434 ranked researchers
- Rank in United States
- #59,064 of 1,627,098
- Works
- 189
- Citations
- 14k
- Citations per work
- 72.4
What does Suresh Vedantham research?
Suresh Vedantham's work is mostly in Medicine (67%), Health Professions (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences14878.5%
- Medicine12666.7%
- Health Professions2211.8%
- Everything else4121.5%
- 1Surgery28% of their works
- 2Internal Medicine25% of their works
- 3Emergency Medical Services12% of their works
- 4Cardiology and Cardiovascular Medicine6% of their works
- 5Pulmonary and Respiratory Medicine5% of their works
- 6Epidemiology2% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Diagnosis and Treatment of Venous Diseases
- Central Venous Catheters and Hemodialysis
- Peripheral Artery Disease Management
- Atrial Fibrillation Management and Outcomes
- Vascular Procedures and Complications
- Acute Ischemic Stroke Management
- Blood Coagulation and Thrombosis Mechanisms
Which keywords describe Suresh Vedantham's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Risk Factors, Antithrombotic Therapy, Pulmonary Embolism, Venous Thromboembolism, Chronic Venous Insufficiency, Varicose Veins and Catheter-Related Infections.
- Thrombin
- Thrombolysis
- Radial Access
- Hemostasis
- Anticoagulant Therapy
- Angioplasty
- Guidelines
- Catheter-Related Infections
- Chronic Venous Insufficiency
- Pulmonary Embolism
- Risk Factors
- Clinical Practice Guidelines
- Antithrombotic Therapy
- Venous Thromboembolism
- Varicose Veins
- Central Venous Catheterization
- Revascularization
- Peripheral Arterial Disease
- Atrial Fibrillation
- Femoral Access
- Ischemic Stroke
- Protease-Activated Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Practice Guidelines2192 topics
- Risk Factors1613 topics
- Antithrombotic Therapy1372 topics
- Pulmonary Embolism1291 topic
- Venous Thromboembolism1291 topic
- Chronic Venous Insufficiency901 topic
- Varicose Veins901 topic
- Catheter-Related Infections611 topic
- Central Venous Catheterization611 topic
- Guidelines452 topics
- Revascularization322 topics
- Angioplasty231 topic
- Peripheral Arterial Disease231 topic
- Anticoagulant Therapy221 topic
- Atrial Fibrillation221 topic
- Hemostasis192 topics
- Femoral Access111 topic
- Radial Access111 topic
- Ischemic Stroke91 topic
- Thrombolysis91 topic
- Protease-Activated Receptors81 topic
- Thrombin81 topic
Where does Suresh Vedantham work?
Suresh Vedantham's main affiliation in the publication record is Mallinckrodt (United States), United States.
How many publications and citations does Suresh Vedantham have?
OpenAlex counts 189 works and 13,691 citations for Suresh Vedantham, an h-index of 49, ranking #156,923 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suresh Vedantham. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.